Boehringer Ingelheim (Canada) Ltd. et al. v. Dr. Reddy's Laboratories Ltd.

Call to arrange a consultation

2025

T-1002-25

Resolved

6(1) PM(NOC) Regulations

Application under subsection 6(1) of the Patented Medicines (Notice of Compliance) Regulations regarding empagliflozin.

Counsel to:

Dr. Reddy's Laboratories Ltd.

The decision is reported

Counsel

Partner

Associate